Related Experiment Video
Updated: Jun 20, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Targeting the HSPA8-CMA-ATP6V1A Axis Triggers Lysosomal Hyperacidification and Catastrophic Vacuolation in Prostate
Bingzheng An1, Ze Gao1, Shuo Chen2
1Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Abstract:
Prostate cancer (PCa) ranks among the most common and deadly malignancies worldwide. The clinical treatment of advanced prostate cancer is particularly challenging due to acquired drug resistance. Autophagy and lysosome-related pathways are key drivers of this resistance. Targeting the lysosome represents a potential therapeutic strategy for PCa. In this study, we identified Heat Shock Protein Family A Member 8 (HSPA8) as a critical functional node of Aloperine (ALO). ALO suppresses autophagic flux, disrupts lysosomal homeostasis, and induces lysosomal vacuolation in cancer cells by inhibiting the function of HSPA8, impairing chaperone-mediated autophagy (CMA)-mediated ATP6V1A degradation. The resulting pathological accumulation and enhanced V1-V0 association of the V-ATPase complex drive pronounced lysosomal hyperacidification and severe osmotic swelling. This biochemical and physical stress is associated with lysosomal membrane permeabilization (LMP) and downstream loss of lysosomal integrity. Furthermore, we reveal that ALO-induced vacuolation triggers a compensatory upregulation of cholesterol biosynthesis to buffer membrane expansion; preemptively disrupting this adaptive response with the DHCR7 inhibitor AY9944 yields significant synergistic lethality. Collectively, our findings reveal the specific cytotoxic mechanism of ALO and demonstrate that pharmacological targeting of the HSPA8-CMA-ATP6V1A axis is a valuable strategy for inducing lethal lysosomal vacuolation in advanced PCa.
Insights
Aloperine (ALO) targets Heat Shock Protein Family A Member 8 (HSPA8) to disrupt lysosomal function in advanced prostate cancer (PCa). This induces lethal vacuolation, offering a new therapeutic strategy for drug-resistant PCa.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Advanced prostate cancer (PCa) presents significant treatment challenges due to acquired drug resistance.
- Autophagy and lysosome-related pathways are implicated as key mechanisms driving this resistance.
- Targeting lysosomal function offers a promising therapeutic avenue for PCa.
Purpose of the Study:
- To elucidate the specific cytotoxic mechanism of Aloperine (ALO) in advanced PCa.
- To identify Heat Shock Protein Family A Member 8 (HSPA8) as a critical functional node for ALO's action.
- To evaluate the therapeutic potential of targeting the HSPA8-CMA-ATP6V1A axis.
Main Methods:
- Investigated ALO's effect on cancer cell autophagy and lysosomal homeostasis.
- Assessed the role of HSPA8 in ALO-induced lysosomal dysfunction and vacuolation.
- Examined the impact of ALO on V-ATPase complex, lysosomal pH, and membrane integrity.
- Evaluated the synergistic effect of combining ALO with a DHCR7 inhibitor (AY9944).
Main Results:
- ALO inhibits HSPA8, impairing chaperone-mediated autophagy (CMA)-mediated ATP6V1A degradation.
- This leads to lysosomal accumulation, hyperacidification, osmotic swelling, and lysosomal membrane permeabilization (LMP).
- ALO-induced vacuolation upregulates cholesterol biosynthesis; inhibiting this pathway synergistically enhances lethality.
Conclusions:
- ALO induces cancer cell death by triggering lethal lysosomal vacuolation via HSPA8 inhibition.
- Targeting the HSPA8-CMA-ATP6V1A axis represents a novel strategy for treating advanced, drug-resistant PCa.
- Combination therapy with DHCR7 inhibitors may enhance ALO's efficacy.
Related Concept Videos
Lysosomal Hydrolases
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
Cancer Cell Migration through Invadopodia
Abnormal Proliferation

